MY141728A - Uv-stable, liquid or semi-solid transdermal administration form comprising a photosensitive active ingredient - Google Patents

Uv-stable, liquid or semi-solid transdermal administration form comprising a photosensitive active ingredient

Info

Publication number
MY141728A
MY141728A MYPI20045109A MYPI20045109A MY141728A MY 141728 A MY141728 A MY 141728A MY PI20045109 A MYPI20045109 A MY PI20045109A MY PI20045109 A MYPI20045109 A MY PI20045109A MY 141728 A MY141728 A MY 141728A
Authority
MY
Malaysia
Prior art keywords
active ingredient
semisolid
pharmaceutical preparation
transdermal administration
liquid
Prior art date
Application number
MYPI20045109A
Inventor
Podhaisky Hans-Peter
Bracht Stefan
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34486168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY141728(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of MY141728A publication Critical patent/MY141728A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

THE SEMISOLID OR LIQUID PHARMACEUTICAL PREPARATION FOR TRANSDERMAL ADMINISTRATION CONTAINS AT LEAST ONE UV-LIGHT SENSITIVE PHARMACEUTICALLY ACTIVE INGREDIENT AND AT LEAST ONE UV-ABSORBING SUBSTANCE, WHICH IS PRESENT IN AN AMOUNT THAT DOES NOT HAVE PHARMACOLOGICAL ACTIVITY AND IN DISSOLVED OR DISPERSED FORM. THIS SEMISOLID OF LIQUID PHARMACEUTICAL PREPARATION IS PREFERABLY A HYDROALCOHOLIC GEL, WHOSE GEL BASE INCLUDES WATER, ALCOHOL, AT LEAST ONE GEL-FORMING POLYMER AND ADDITIONAL INGREDIENTS AS NEEDED. THIS PHARMACEUTICAL PREPARATION IS PREPARED WITH A UV-LIGHT SENSITIVE PHARMACEUTICALLY ACTIVE INGREDIENT, SO THAT THE APPLICATION SYSTEM HAS A HIGH STABILITY WITHOUT THE DISADVANTAGES OF THE KNOWN SEMISOLID TRANSDERMAL APPLICATION FORMS. THE INJURIOUS SIDE EFFECTS, SUCH AS ABSORPTION OF THE UV-LIGHT PROTECTING INGREDIENT IN THE BODY, RESULTING FROM THE INTENDED LIGHT PROTECTION ARE REDUCED AS MUCH AS POSSIBLE.
MYPI20045109A 2003-12-10 2004-12-10 Uv-stable, liquid or semi-solid transdermal administration form comprising a photosensitive active ingredient MY141728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03028353A EP1541136A1 (en) 2003-12-10 2003-12-10 UV light-stable semi-solid transdermal systems comprising a photosensitive active agent and an UV-absorbing component

Publications (1)

Publication Number Publication Date
MY141728A true MY141728A (en) 2010-06-15

Family

ID=34486168

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20045109A MY141728A (en) 2003-12-10 2004-12-10 Uv-stable, liquid or semi-solid transdermal administration form comprising a photosensitive active ingredient

Country Status (24)

Country Link
EP (2) EP1541136A1 (en)
JP (1) JP2007534643A (en)
KR (1) KR20060096512A (en)
CN (1) CN101415402A (en)
AR (1) AR047140A1 (en)
AU (1) AU2004296539B2 (en)
BR (1) BRPI0416979A (en)
CA (1) CA2548739C (en)
CR (1) CR8461A (en)
EA (1) EA010239B1 (en)
EC (1) ECSP066689A (en)
GT (1) GT200400261A (en)
HN (1) HN2004000525A (en)
IL (1) IL176208A0 (en)
MX (1) MXPA06006534A (en)
MY (1) MY141728A (en)
NO (1) NO20063208L (en)
NZ (1) NZ547733A (en)
PE (1) PE20050863A1 (en)
SV (1) SV2006001971A (en)
TW (1) TW200528136A (en)
UA (1) UA85861C2 (en)
WO (1) WO2005055975A2 (en)
ZA (1) ZA200605632B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI395806B (en) 2010-04-14 2013-05-11 Ind Tech Res Inst Packaging material
SI2613772T1 (en) * 2010-09-06 2017-03-31 Bayer Intellectual Property Gmbh Low-dose transdermal patches with high drug release
WO2014152122A2 (en) * 2013-03-15 2014-09-25 Children's Medical Center Corporation Methods of altering vascular permeability and uses thereof
JP2024000555A (en) * 2022-06-21 2024-01-09 東ソー株式会社 Method for producing estradiol measurement reagent under ultraviolet ray suppression

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (en) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc Stable pharmaceutical for external use containing "ketoprofen(r)"
JP2981523B2 (en) * 1990-11-19 1999-11-22 株式会社林原生物化学研究所 External preparation for skin
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
CA2301016A1 (en) * 1997-08-21 1999-02-25 Johnson & Johnson Consumer Companies, Inc. Use of 17-.alpha.-estradiol for the treatment of aged or sundamaged ski n and/or skin atrophy
JP2000292428A (en) * 1999-04-05 2000-10-20 Umeda Jimusho:Kk New measurement method and device of internal secretion disturbance activity of environmental chemical substance
JP2001129566A (en) * 1999-11-05 2001-05-15 Mitsubishi Heavy Ind Ltd Method and apparatus for treating harmful substance
FR2804024B1 (en) * 2000-01-21 2002-09-13 Menarini France NOVEL PHARMACEUTICAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTION AND PROCESS FOR THEIR PREPARATION
DE10053375C1 (en) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermal therapeutic system with light-sensitive agent in polymer matrix and backing, useful for therapy with e.g. nicotine, nifedipine, lacidipine, gestagen, vitamin B 12 or antibiotic, contains colorless ultraviolet absorber
FR2834895B1 (en) * 2002-01-22 2006-06-23 Ellipse Pharmaceuticals WATER-RESISTANT, DERMATOLOGICAL COMPOSITIONS WITH SOLAR FILTERS, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF
ITFI20020144A1 (en) * 2002-08-01 2004-02-02 Menarini Farma Ind STABILIZED TOPICAL FORMULATIONS CONTAINING KETOPROFENE.

Also Published As

Publication number Publication date
WO2005055975A3 (en) 2009-03-12
CN101415402A (en) 2009-04-22
GT200400261A (en) 2005-10-31
HN2004000525A (en) 2010-09-17
TW200528136A (en) 2005-09-01
IL176208A0 (en) 2006-10-05
CA2548739A1 (en) 2005-06-23
NZ547733A (en) 2010-02-26
JP2007534643A (en) 2007-11-29
EP1541136A1 (en) 2005-06-15
ECSP066689A (en) 2006-10-31
EA010239B1 (en) 2008-06-30
AR047140A1 (en) 2006-01-11
CA2548739C (en) 2009-08-18
UA85861C2 (en) 2009-03-10
SV2006001971A (en) 2006-02-15
WO2005055975A2 (en) 2005-06-23
EA200601084A1 (en) 2006-12-29
AU2004296539A1 (en) 2005-06-23
KR20060096512A (en) 2006-09-11
MXPA06006534A (en) 2006-08-01
NO20063208L (en) 2006-07-10
AU2004296539B2 (en) 2008-10-09
ZA200605632B (en) 2008-06-25
PE20050863A1 (en) 2005-11-02
CR8461A (en) 2006-12-07
EP1703892A2 (en) 2006-09-27
BRPI0416979A (en) 2007-02-21

Similar Documents

Publication Publication Date Title
AU2013323766B2 (en) Topical ketoprofen composition
TR200003158T2 (en) Gelling pharmaceutical compositions
DE69520492D1 (en) LIQUID MEDICINAL PREPARATIONS CONTAINING THYROID HORMONES
BRPI0410542A (en) eye drug delivery device and method of administering a pharmaceutically active agent to an eye
DE60027463D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RESVERATROL AND USES THEREOF
DE59009495D1 (en) Active substance plaster containing estrogen.
EP1094781A4 (en) FAST AND NON-IRRITATING TRANSDERMAL DELIVERY COMPOSITIONS OF ACTIVE PHARMACEUTICAL AGENTS AND METHODS FOR THE FORMULATION AND DELIVERY OF SUCH COMPOSITIONS
DE69430132D1 (en) PERNASAL COMPOSITION AND PERNASALE PREPARATION CONTAINING IT
DK1311249T3 (en) Set of transdermal therapeutic systems
ES2171933T3 (en) ANDROSTENO DERIVATIVES.
ES2526562T3 (en) External preparation for percutaneous administration containing non-steroidal anti-inflammatory analgesic
CA2602018A1 (en) A transdermal topical composition and its uses
BR9904541A (en) Cosmetic composition for topical use, use of the composition and use of at least one derivative of cinnamic acid and / or at least one derivative of salicylic acid
ES2186207T3 (en) METHOD FOR PREPARATION OF PHARMACEUTICAL FORMULATIONS.
MY141728A (en) Uv-stable, liquid or semi-solid transdermal administration form comprising a photosensitive active ingredient
CZ2002488A3 (en) Transdermal administration of lasofoxifene
Carmichael et al. Allergic contact dermatitis from oestradiol in oestrogen patches.
AU2004264332B2 (en) Method and composition for treating burned skin
EP0756870B1 (en) Pharmaceutical compositions for topic use on the basis of ketoprofen
PT874630E (en) COMBINED THERAPY OF A TOPOISOMERASE II INHIBITOR AND A BIS DIOXIPIPERAZINE DERIVATIVE
EA200101157A1 (en) 14β-H-STEROLS CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND THE APPLICATION OF THESE DERIVATIVES FOR THE PREPARATION OF MEDICINES OF REGULATING MEIOSE
Santoro et al. Assessment of skin safety of a new glyceryl trinitrate transdermal patch
BR9912260A (en) Plaster containing a transdermal therapeutic system and a single dose for administration
CU20060115A7 (en) FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS
OGISO et al. Anti-inflammatory activity of ointments of indomethacin and its calcium salt applied to abdominal skin of rat